Skip to main navigation
Skip to search
Skip to main content

Search All UT System Experts

University of Texas Southwestern Medical Center Home

Home
Profiles
Research units
Equipment
Research output

Search by expertise, name or affiliation

Erlotinib (Tarceva): Potent HER1/epidermal growth factor receptor inhibition: Introduction

Carlos L. Arteaga

Simmons Comprehensive Cancer Center - Administration - Directors Office - Administration
Simmons Comprehensive Cancer Center

Research output: Contribution to journal › Article › peer-review

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'Erlotinib (Tarceva): Potent HER1/epidermal growth factor receptor inhibition: Introduction'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2024 Elsevier B.V. or its licensors and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility

Report vulnerability